L-theanine is an amino acid found in green tea shown in randomised controlled trials to reduce stress response and improve sleep quality at doses of 200-400mg, with Kimura et al. (2007) documenting significant reductions in stress markers. This Ireland guide covers dosing protocols, safety considerations, drug interactions, and how to evaluate L-theanine supplement quality against FSAI standards.  

Magnesium glycinate has demonstrated improved sleep quality in randomised controlled trials including Bannai et al. (2012) and Kawai et al. (2015), with the glycine component acting on NMDA receptors to reduce core body temperature and promote sleep onset. This Ireland guide covers HSE recommended daily allowances, safe upper intake levels, and how magnesium glycinate compares to citrate for Irish consumers.

Magnesium glycinate delivers approximately 14% elemental magnesium per dose with superior gastrointestinal tolerance versus magnesium citrate at 16% elemental magnesium, which carries higher laxative risk at elevated doses. This Ireland guide covers HSE recommended daily allowances, FSAI tolerable upper intake levels, and how to read elemental magnesium content on Irish supplement labels.

Magnesium glycinate and magnesium bisglycinate are functionally identical compounds — bisglycinate simply confirms both bonding sites on the magnesium ion are occupied by glycine, improving gastrointestinal tolerance at the HSE recommended daily allowance of 300mg for women and 350mg for men. This Ireland guide covers elemental magnesium content, label decoding, FSAI safe upper intake levels, and how to compare glycinate products for Irish consumers.

Magnesium bisglycinate is trending in Ireland for muscle cramps, sleep, stress and daily wellness. Here’s what it is, how much to take, and how to choose the right supplement safely.

Intensive bowel support protocols use high-CFU multi-strain probiotics during active flares of IBD, IBS, and pouchitis, with the De Simone formulation studied at doses up to 3,600 billion CFU in peer-reviewed trials referenced in ECCO IBD guidelines. CDS22 is available in Ireland at 450 billion CFU per sachet and 112 billion CFU per capsule, making it the highest-potency De Simone formulation accessible to Irish patients.

Lactobacillus gasseri is an autochthonous human gut strain with randomised controlled trial evidence for abdominal fat reduction and IBS symptom management, with strain-specific studies including Kadooka et al. (2010) documenting significant reductions in visceral fat. This Ireland guide covers DSM strain codes, DRcaps delivery mechanisms, FSAI health claim regulations, and how to evaluate Lactobacillus gasseri supplements for Irish consumers.

N-Acetyl Cysteine (NAC) is a glutathione precursor with peer-reviewed evidence for mucolytic activity, liver protection, and oxidative stress reduction, studied at doses of 600mg to 1,800mg daily across multiple randomised controlled trials. This Ireland guide covers FSAI regulatory status, safe dosing thresholds, drug interactions including paracetamol overdose protocols, and how to evaluate NAC supplement quality for Irish consumers

The De Simone formulation comprises 8 specific strains including Lactobacillus acidophilus DSM 24735 and Bifidobacterium longum DSM 24736, developed by Professor Claudio De Simone and separated from VSL#3 via US and Italian court rulings in 2016. CDS22 is the current authorised product in Ireland containing this formulation, with the full legal timeline, strain certificates, and clinical trial index documented in this reference guide.

This pharmacy-grade Ireland guide applies strain-specific evidence, CFU viability, storage requirements, and FSAI regulatory criteria to evaluate leading probiotic products including CDS22, Symprove, Optibac, and Alflorex. Antibiotic timing protocol covered: 2-hour separation rule, 7–14 days post-course continuation, with reference to HSE and FSAI guidance for Irish consumers.

reland guide: Can you take probiotics with antibiotics? Yes — 2-hour gap rule recommended. Continue 7–14 days post-course. Antibiotic-associated diarrhoea risk 5–30%. Evidence reviewed for Lactobacillus rhamnosus GG and Saccharomyces boulardii with FSAI and HSE regulatory context for Irish consumers.

Berberine's AMPK activation mechanism modulates gut microbiome composition, with research suggesting concurrent probiotic use may attenuate berberine-induced disruption of beneficial Lactobacillus and Bifidobacterium populations. This Ireland guide covers the evidence for combining berberine at 500mg three times daily with multi-strain probiotics, timing protocols, and FSAI safety considerations for Irish consumers.